What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value?

BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value is -$12.4M, based on as-reported figures from SEC (XBRL) filings.

What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM)?

BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM) is -$182.1M, based on as-reported figures from SEC (XBRL) filings.

What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.27, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

BridgeBio Oncology Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01L3GYF11

2.66▼ 0.19 (-6.67%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 2.85
Day's Range: 2.60 – 2.83
52-Week Range: 2.60 – 14.87
Volume: 735.4K
Avg Volume: 622.0K

Share Statistics

Shares Outstanding
Employees: 92
Exchange: XNAS
Listed: 2025-08-12

Share count as of August 6, 2026

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Market Cap?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Market Cap is $213.3M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value is -$12.4M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's EV / EBITDA?: BridgeBio Oncology Therapeutics, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM)?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM) is -$182.1M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's EBITDA?: BridgeBio Oncology Therapeutics, Inc. Common Stock's EBITDA is -$198.6M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.27, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Debt?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Debt is -$225.7M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · BBOTAs-filed SEC (XBRL) data